Detalles de la búsqueda
1.
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials.
BMC Cancer
; 23(1): 719, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528390
2.
Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery.
BMC Cancer
; 21(1): 214, 2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653297
3.
Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials.
BMC Cancer
; 21(1): 426, 2021 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865364
4.
Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Tohoku J Exp Med
; 241(1): 1-11, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27980246
5.
Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer.
Cancer Sci
; 105(8): 1015-22, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24974909
6.
The influence of mtDNA deletion on lung cancer cells under the conditions of hypoxia and irradiation.
Lung
; 192(6): 997-1004, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25218334
7.
Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis.
Lung Cancer
; 191: 107799, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669725
8.
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumor.
Biomed Pharmacother
; 163: 114770, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105074
9.
Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review.
Cancer Invest
; 30(10): 741-7, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23075074
10.
Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer.
Lung Cancer
; 166: 9-16, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35151115
11.
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis.
Front Oncol
; 12: 863666, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785185
12.
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies.
Front Pharmacol
; 13: 920165, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034821
13.
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Biomed Res Int
; 2021: 8850256, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33575349
14.
Response to "A meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer".
Cancer Sci
; 106(6): 783, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26054038
15.
Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report.
Front Oncol
; 10: 771, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32547945
16.
Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis.
Radiat Oncol
; 15(1): 205, 2020 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32831120
17.
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials.
Front Oncol
; 10: 586596, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33511076
18.
Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancers.
J Thorac Dis
; 12(3): 839-848, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274151
19.
The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs.
Transl Cancer Res
; 8(5): 1834-1844, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116934
20.
Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma.
Transl Cancer Res
; 8(5): 2151-2163, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116965